New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...

Tecentriq in combination with bevacizumab will help the 70 or so New Zealanders diagnosed with Hepatocellular Carcinoma (HCC) ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a global health ...

Immune-Onc Therapeutics has dosed the first subject in the Phase Ib/II trial of IO-108 plus Roche’s atezolizumab and ...

PYX-201 has gained FDA fast track designation in recurrent or metastatic head and neck squamous cell carcinoma.

16-year-old Indian youth, Aditya Kumar Jha from VIBGYOR High School, Mumbai, has established himself as a force to be ...

The panelist discusses the case of a 60-year-old man diagnosed with unresectable hepatocellular carcinoma (HCC). The patient has a history of metabolic dysfunction-associated steatohepatitis managed ...

Metformin is a medication prescribed to help manage type 2 diabetes. Recent research suggests, however, this medication may ...

Spleen volume was linked with an increased risk of IBD in a Mendelian randomization study. (Scientific Reports) A dual ...

经过DataTwin图像查重流程，发现李春晓、江萍、王俊杰团队等人近期在某权威期刊上发表的"Sorafenib enhanced the function of myeloid-derived suppressor cells in ...

Researchers from Medizinische Hochschule Hannover and affiliated organizations reported data from studies aimed to identify non-coding microRNAs (miRNAs) with therapeutic potential against liver ...

Drayson started taking cancer drugs atezolizumab with bevacizumab in December 2023 after being accepted for a clinical trial.